| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Mbx Biosciences IncMBX | +145.70% | $12.43 | $30.54 | 2025-07-15 - 2026-03-03 | Buy |
Palvella Therapeutics IncPVLA | +131.90% | $56.71 | $131.51 | 2025-09-08 - 2026-03-03 | Buy |
Ligand Pharmaceuticals IncLGND | +95.48% | $104.48 | $204.24 | 2025-05-08 - 2026-03-03 | Buy |
Ligand Pharmaceuticals IncLGND | +62.24% | $122.23 | $198.31 | 2025-02-27 - 2026-02-27 | Buy |
Mbx Biosciences IncMBX | +61.08% | $18.96 | $30.54 | 2025-09-22 - 2026-03-03 | Buy |
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ligand Pharmaceuticals IncLGND | 8 | Buy | $277.00 | +35.62% | Maintains | 5 days ago |
Bridgebio Pharma IncBBIO | 2 | Buy | $81.00 | +25.52% | Maintains | 7 days ago |
Legend Biotech CorpLEGN | 1 | Buy | $75.00 | +319.93% | Initiates Coverage On | 2 months ago |
Design Therapeutics IncDSGN | 1 | Buy | $18.00 | +80.00% | Initiates Coverage On | 2 months ago |
Theravance Biopharma IncTBPH | 1 | Buy | $27.00 | +93.41% | Initiates Coverage On | 3 months ago |
Mbx Biosciences IncMBX | 2 | Buy | $80.00 | +161.95% | Maintains | 5 months ago |
Palvella Therapeutics IncPVLA | 1 | Buy | $85.00 | -35.37% | Initiates Coverage On | 6 months ago |
Innoviva IncINVA | 1 | Buy | $35.00 | +56.95% | Initiates Coverage On | 7 months ago |